LOAMS
Lombard Odier Asset Management (Switzerland) Portfolio holdings
AUM
$1.98B
This Quarter Return
-6.61%
1 Year Return
+25.93%
3 Year Return
+103.45%
5 Year Return
+160.5%
10 Year Return
+469.02%
AUM
$1.27B
AUM Growth
+$1.27B
(-19%)
Cap. Flow
-$128M
Cap. Flow
% of AUM
-10.05%
Top 10 Holdings %
Top 10 Hldgs %
24.84%
Holding
415
New
40
Increased
54
Reduced
57
Closed
258
Top Buys
| 1 |
CVS Health
CVS
|
$33M |
| 2 |
Incyte
INCY
|
$26.4M |
| 3 |
Bristol-Myers Squibb
BMY
|
$24.7M |
| 4 |
Halozyme
HALO
|
$24.5M |
| 5 |
Equity Lifestyle Properties
ELS
|
$22.9M |
Top Sells
| 1 |
Pultegroup
PHM
|
$28.6M |
| 2 |
Biogen
BIIB
|
$24.6M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$24.1M |
| 4 |
Abbott
ABT
|
$15.5M |
| 5 |
Pool Corp
POOL
|
$14.2M |
Sector Composition
| 1 | Healthcare | 56.62% |
| 2 | Financials | 13.8% |
| 3 | Consumer Discretionary | 12.01% |
| 4 | Technology | 6.24% |
| 5 | Energy | 3.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Natera
NTRA
$23B
| $8.09M | 0.63% |
198,824
-34,293
| -15% | -$1.4M |
|
52
Editas Medicine
EDIT
$225M
| $7.25M | 0.57% |
380,963
+67,641
| +22% | +$1.29M |
|
53
Itaú Unibanco
ITUB
$74.8B
| $7.15M | 0.56% |
+1,377,860
| New | +$7.15M |
|
54
Iovance Biotherapeutics
IOVA
$800M
| $6.86M | 0.54% |
412,262
-537,622
| -57% | -$8.95M |
|
|
NVTA
55
DELISTED
Invitae Corporation
NVTA
| $6.76M | 0.53% |
847,825
+57,429
| +7% | +$458K |
|
56
Fate Therapeutics
FATE
$115M
| $6.64M | 0.52% |
171,325
-100,686
| -37% | -$3.9M |
|
57
Quanterix
QTRX
$202M
| $6.38M | 0.5% |
218,547
-50,515
| -19% | -$1.47M |
|
58
10x Genomics
TXG
$1.66B
| $6.11M | 0.48% |
80,276
-75,676
| -49% | -$5.76M |
|
59
NVIDIA
NVDA
$4.15T
| $5.77M | 0.45% |
211,530
+31,840
| +18% | +$869K |
|
60
Intellia Therapeutics
NTLA
$1.26B
| $5.75M | 0.45% |
79,089
-34,222
| -30% | -$2.49M |
|
61
Karyopharm Therapeutics
KPTI
$61.4M
| $5.72M | 0.45% |
51,737
-58,799
| -53% | -$6.5M |
|
62
Sangamo Therapeutics
SGMO
$161M
| $5M | 0.39% |
860,702
-679,292
| -44% | -$3.95M |
|
63
Huazhu Hotels Group
HTHT
$11.2B
| $4.84M | 0.38% |
+146,828
| New | +$4.84M |
|
64
Allogene Therapeutics
ALLO
$249M
| $4.57M | 0.36% |
501,219
-494,897
| -50% | -$4.51M |
|
|
GTHX
65
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $4.12M | 0.32% |
542,183
-507,764
| -48% | -$3.86M |
|
66
Meta Platforms (Facebook)
META
$1.85T
| $4.02M | 0.32% |
18,086
+820
| +5% | +$182K |
|
67
Nike
NKE
$110B
| $3.8M | 0.3% |
28,213
+2,362
| +9% | +$318K |
|
68
PepsiCo
PEP
$203B
| $3.78M | 0.3% |
22,573
+9,646
| +75% | +$1.61M |
|
69
Kura Oncology
KURA
$732M
| $3.77M | 0.3% |
234,372
+15,875
| +7% | +$255K |
|
70
Danaher
DHR
$143B
| $3.61M | 0.28% |
13,892
+10,729
| +339% | +$2.79M |
|
71
Procter & Gamble
PG
$370B
| $3.59M | 0.28% |
23,479
+5,891
| +33% | +$900K |
|
72
Salesforce
CRM
$245B
| $3.44M | 0.27% |
16,185
+677
| +4% | +$144K |
|
73
Coca-Cola
KO
$297B
| $3.29M | 0.26% |
53,063
+22,208
| +72% | +$1.38M |
|
74
Sutro Biopharma
STRO
$85.6M
| $3.21M | 0.25% |
391,024
-137,418
| -26% | -$1.13M |
|
|
MRTX
75
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.21M | 0.25% |
39,092
-82,644
| -68% | -$6.79M |
|